Bio-Path Holdings reports net loss of $504,876 for first quarter 2014


Posted in: Business / Finance

Tags: Antisense, Biotechnology, Blood, Cancer, Cell, Clinical Trial, Drug Delivery, Drugs, Leukemia, Liposome, Lymphoma, Oncology, Protein, technology, Tumor, Tyrosine